PD-1 can be also expressed in TILs and, on the other hand, tumor cells can express PD‐L1 in different percentage, contributing to the inhibition of CD4+ and CD8+ T-cell activation and to the apoptosis of antigen-specific T-cell clones (83, 84). This evidence concerns the gene CD8A and neoplasm.